Inari Medical soars on Stryker acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
BTIG Downgrades Inari Medical Inc. (NARI) to Neutral
January 7, 2025 4:09 PM UTCBTIG analyst Marie Thibault downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Neutral.
The analyst comments "We are downgrading NARI shares to Neutral following the announcement on Monday, January 6 that Stryker (SYK, Buy, $394 PT; Analyst: Zimmerman) entered a definitive agreement to... More
Jefferies Downgrades Inari Medical Inc. (NARI) to Hold
January 7, 2025 11:49 AM UTCJefferies analyst Matthew Taylor downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Hold with a price target of $80.00 (from $70.00).
The analyst comments "After the market close, SYK announced an agreement to acquire NARI for $80/shr in cash, equating to a fully... More
BofA Securities Reiterates Buy Rating on Stryker (SYK)
January 7, 2025 8:07 AM UTCBofA Securities analyst Travis Steed reiterated a Buy rating and $450.00 price target on Stryker (NYSE: SYK)
The analyst comments "Inside we include our pro forma deal model. We estimate the EPS dilution in year 1 is only slightly dilutive (around 1-3% dilutive) and... More
